Your Shopping Cart Is Empty
| Report Code: A12521 | Jul 2021 | Pages: 190 | ||
| Tables: 91 | Charts: 21 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Contrast Media Injectors Market
Request Now !The global contrast media injectors market size was valued at $1,405.90 million in 2020, and is estimated to reach $2,608.20 million by 2030, growing at a CAGR of 8.00% from 2021 to 2030.
negatively impacted growth of the global contrast media injectors market. During COVID-19 pandemic, many radiology departments have experienced a rapid decline in imaging case volume, which impede the market growth.
Contrast media injectors are instruments used to control contrast material prior to diagnostic imaging techniques, such as CT or MRI scans, to increase the image quality. Contrast media injectors include features, such as preset protocols and safety mechanisms, to avoid extravasation of contrast media by physicians. Counter media injectors may lessen the risk of undesirable consequences, such as the formation of air emboli, caused by inappropriate contrast material injection. As they minimize the volume of contrast view, the contrast of the injectors is substantially increased.
The COVID-19 pandemic has a severe global impact on population health as well as a significant economic impact on majority of countries. The pandemic has put enormous strain on the world's healthcare systems. During this time, health care institutions and providers have been told to avoid performing elective surgical procedures and medical examinations to slow disease spread and conserve health care resources for COVID-19 patients. Many radiology departments have witnessed a significant decrease in imaging case volume. Depending on the location of practice and the severity of the COVID-19 pandemic in each region, radiology offices should expect 50% to 70% decline in imaging volume that will persist for at least 3 to 4 months while the future appears to be uncertain due to COVID-19. The demand for contrast injectors will be primarily determined by the amount of diagnostic imaging and the number of CT and MRI installations. We may expect diagnostic imaging demand to return to normalcy in a few months, which may also lead to a recovery in demand for contrast injectors.
Factors, such as the rising prevalence of cancer and CVD, a significant number of contrast agent approvals, and increased investments, funding, & grants from government organizations, are propelling the contrast media injectors market growth. However, the high cost of contrast media injectors and consumables and accessories is limiting the market expansion to some extent.
The contrast media injectors market is segmented on the basis of product type, application, end-user, and region. By product type, the market is categorized into consumables, injector systems, and accessories. By application, it is fragmented into radiology, interventional cardiology, and interventional radiology. By end user, it is segregated into hospitals, ambulatory surgery centers, and diagnostics imaging centers.
Region-wise, the contrast media injectors market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
On the basis of product type, the consumables segment is expected to witness the highest growth rate during the forecast period. The high growth rate in this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. On the basis of application, the radiology segment will continue to dominate the applications segment of the contrast media injector market during the forecast period. This is attributed to the rising number of radiology procedures using contrast media.
North America accounted for a major share in the contrast media injectors market in 2020, and is expected to maintain its dominance during the forecast period, owing to well-established healthcare infrastructure. Furthermore, factors, such as growing preference for minimally invasive procedures and an increase in the prevalence of chronic diseases as a result of changing lifestyles, propel the market growth. The Asia Pacific market, on the other hand, is predicted to grow at the fastest CAGR during the forecast period, owing to factors such as increased R&D investments, favorable demographic scenario in China, aging population, and cancer incidences in Japan. There is growing investment in the India radiology market as well as increased attention of market participants and government support to boost healthcare service delivery in Asia-Pacific.
The key players operating in the global contrast media injectors market include Bayer HealthCare LLC; Bracco Imaging S.P.A, Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd., APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., and Medtron AG.
Key Benefits For Stakeholders
Key Market Segments
By Product Type
By Application
By End User
By Region
KEY MARKET PLAYERS
Contrast Media Injectors Market Report Highlights
| Aspects | Details |
|---|---|
| By Product Type |
|
| By Application |
|
| By End User |
|
| By Region |
|
| Key Market Players | APOLLO RT CO. LTD., MEDTRON AG, NEMOTO KYORINDO CO., LTD., THE GUERBET GROUP, BRACCO S.P.A., ULRICH GmbH & CO. KG, SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD., SHENZHEN ANKE HIGH-TECH CO., LTD., BAYER AG, SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD. |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies, 2020
3.3.Porter’s five forces analysis
3.3.1.Top player positioning
3.4.Market dynamics
3.4.1.Drivers, restraints, and opportunity
3.4.2.Drivers
3.4.2.1.Increasing prevalence of cancer and cardiovascular diseases
3.4.2.2.Increase in unhealthy lifestyle
3.4.3.Restraints
3.4.3.1.High cost of contrast media injectors, consumables and accessories
3.4.4.Opportunity
3.4.4.1.Artificial intelligence to provide faster results
3.4.4.2.Increasing demand for MRI scans
3.5.Impact of COVID-19 on Contrast media injectors market
3.5.1.Overview
3.5.2.Impact analysis
CHAPTER 4:CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by types
4.2.4.1.Syringes market size and forecast
4.2.4.2.Tubes market size and forecast
4.2.4.3.Other consumablesmarket size and forecast
4.3.Injector Systems
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Injector Systems market size and forecast, by type
4.3.4.1.CT Injectors market size and forecast
4.3.4.2.MRI Injectors market size and forecast
4.3.4.3.Angiography Injectors market size and forecast
4.4.Accessories
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Radiology
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Interventional Radiology
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Interventional Cardiology
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:CONTRAST MEDIA INJECTORS MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospital
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Diagnostic Imaging Centers
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Ambulatory surgery centers
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:CONTRAST MEDIA INJECTORS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key opportunities and forecast
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by product
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by end user
7.2.5.1.U.S.
7.2.5.1.1.U.S. market size and forecast, by product
7.2.5.1.2.U.S. market size and forecast, by application
7.2.5.1.3.U.S. market size and forecast, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada market size and forecast, by Product
7.2.5.2.2.Canada market size and forecast, by application
7.2.5.2.3.Canada market size and forecast, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico market size and forecast, by product
7.2.5.3.2.Mexico market size and forecast, by application
7.2.5.3.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key opportunities and forecast
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by product
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by end user
7.3.5.1.Germany
7.3.5.1.1.Germany market size and forecast, by product
7.3.5.1.2.Germany market size and forecast, by application
7.3.5.1.3.Germany market size and forecast, by end user
7.3.5.2.France
7.3.5.2.1.France market size and forecast, by product
7.3.5.2.2.France market size and forecast, by application
7.3.5.2.3.France market size and forecast, by end user
7.3.5.3.UK
7.3.5.3.1.UK market size and forecast, by product
7.3.5.3.2.UK market size and forecast, by application
7.3.5.3.3.UK market size and forecast, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy market size and forecast, by product
7.3.5.4.2.Italy market size and forecast, by application
7.3.5.4.3.Italy market size and forecast, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain market size and forecast, by Product
7.3.5.5.2.Spain market size and forecast, by application
7.3.5.5.3.Spain market size and forecast, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe market size and forecast, by Product
7.3.5.6.2.Rest of Europe market size and forecast, by application
7.3.5.6.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key opportunities and forecast
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by product
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by end user
7.4.5.1.Japan
7.4.5.1.1.Japan market size and forecast, by Product
7.4.5.1.2.Japan market size and forecast, by application
7.4.5.1.3.Japan market size and forecast, by end user
7.4.5.2.China
7.4.5.2.1.China market size and forecast, by product
7.4.5.2.2.China market size and forecast, by application
7.4.5.2.3.China market size and forecast, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia market size and forecast, by Product
7.4.5.3.2.Australia market size and forecast, by application
7.4.5.3.3.Australia market size and forecast, by end user
7.4.5.4.India
7.4.5.4.1.India market size and forecast, by Product
7.4.5.4.2.India market size and forecast, by application
7.4.5.4.3.India market size and forecast, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Rest of Asia-Pacific market size and forecast, by Product
7.4.5.5.2.Rest of Asia-Pacific market size and forecast, by application
7.4.5.5.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key opportunities and forecast
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by product
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by end user
7.5.5.1.Brazil
7.5.5.1.1.Brazil market size and forecast, by Product
7.5.5.1.2.Brazil market size and forecast, by application
7.5.5.1.3.Brazil market size and forecast, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia market size and forecast, by Product
7.5.5.2.2.Saudi Arabia market size and forecast, by application
7.5.5.2.3.Saudi Arabia market size and forecast, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa market size and forecast, by Product
7.5.5.3.2.South Africa market size and forecast, by application
7.5.5.3.3.South Africa market size and forecast, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA market size and forecast, by Product
7.5.5.4.2.Rest of LAMEA market size and forecast, by application
7.5.5.4.3.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.APOLLO RT CO. LTD.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments
8.2.BAYER AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.BRACCO S.P.A.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.4.MEDTRON AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.NEMOTO KYORINDO CO., LTD.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.SHENZHEN ANKE HIGH-TECH CO., LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments
8.9.THE GUERBET GROUP
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.ULRICH GmbH & CO. KG
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL CONTRAST MEDIA INJECTORS MARKET REVENUE, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY REGION, 2020–2030($MILLION)
TABLE 03.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY APPLICATION, 2020–2030($MILLION)
TABLE 04.SYRINGES MARKET, 2020–2030 ($MILLION)
TABLE 05.TUBES MARKET, 2020–2030 ($MILLION)
TABLE 06.OTHER CONSUMABLES MARKET, 2020–2030 ($MILLION)
TABLE 07.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY REGION, 2020–2028($MILLION)
TABLE 08.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY APPLICATION, 2020–2030($MILLION)
TABLE 09.CT INJECTORS MARKET, 2020–2030 ($MILLION)
TABLE 10.MRI INJECTORS MARKET, 2020–2030 ($MILLION)
TABLE 11.ANGIOGRAPHY INJECTORS MARKET, 2020–2030 ($MILLION)
TABLE 12.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR ACCESSORIES, BY REGION, 2020–2030($MILLION)
TABLE 13.CONTRAST MEDIA INJECTORS MARKET REVENUE, BY APPLICATION, 2020–2030($MILLION)
TABLE 14.CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 15.INTERVENTIONAL RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 16.INTERVENTIONAL CARDIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 17.CONTRAST MEDIA INJECTORS MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 18.CONTRAST MEDIA INJECTORS MARKET FOR HOSPITAL REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 19.CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 20.CONTRAST MEDIA INJECTORS MARKET FOR AMBULATORY SURGERY CENTERS REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 21.CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2020–2030($MILLION)
TABLE 22.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 23.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 24.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 25.NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 26.U.S. CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 27.U.S. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 28.U.S. CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 29.CANADA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 30.CANADA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 31.CANADA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 32.MEXICO CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 33.MEXICO CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 34.MEXICO CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 35.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 36.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 37.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 38.EUROPE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 39.GERMANY CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 40.GERMANY CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 41.GERMANY CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 42.FRANCE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 43.FRANCE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 44.FRANCE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 45.UK CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 46.UK CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 47.UK CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 48.ITALY CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 49.ITALY CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 50.ITALY CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 51.SPAIN CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 52.SPAIN CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 53.SPAIN CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 54.REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 55.REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 56.REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 57.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 58.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 59.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 60.ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 61.JAPAN CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 62.JAPAN CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 63.JAPAN CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 64.CHINA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 65.CHINA. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 66.CHINA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 67.AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 68.AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 69.AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 70.INDIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 71.INDIA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 72.INDIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 73.REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 74.REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 75.REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 76.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 77.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 78.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 79.LAMEA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 80.BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 81.BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 82.BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 83.SAUDI ARABIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 84.SAUDI ARABIA. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 85.SAUDI ARABIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 86.SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 87.SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 88.SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 89.REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 90.REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020–2030($MILLION)
TABLE 91.REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY END USER 2020–2030($MILLION)
LIST OF FIGURES
FIGURE 01.GLOBAL CONTRAST MEDIA INJECTORS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018–2021*
FIGURE 04.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 05.TOP WINNING STRATEGIES: COMPANY , 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 13.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY COUNTRY, 2020–2030(%)
FIGURE 14.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY COUNTRY, 2020–2030(%)
FIGURE 15.CONTRAST MEDIA INJECTORS MARKET REVENUE FOR ACCESSORIES, BY COUNTRY, 2020–2030(%)
FIGURE 16.RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 17.INTERVENTIONAL RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 18.INTERVENTIONAL CARDIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 19.HOSPITAL FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 20.DIAGNOSTIC IMAGING CENTERS FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020–2030(%)
FIGURE 21.AMBULATORY SURGERY CENTERS FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020–2030(%)
The contrast media injectors market gained prominence in 2020, and is expected to witness significant rise in the near future. This is attributed to the growing prevalence of cancer and cardiovascular diseases. As per the World Cancer Report, 2003 by WHO, the number of people suffering from cancer is expected to increase by 50% to 15 million by 2020. Likewise, CVDs and strokes are the leading causes of death around the world. WHO estimated that in 2015, approximately 17.7 million people died of CVDs, which represented 31% of the global deaths and the number is estimated to increase to 23.6 million by 2030.
A large number of approvals for contrast agents and increasing investments, funds, & grants by government organizations are driving the growth of the contrast media injectors market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.
Other key factors expected to drive the market growth are technological advancements in contrast media injector devices and increasing expenditure by key players along with rising regulatory approvals.
A. Contrast delivery is also known as a power injector which is the most effective therapeutic device that can be programmed to deliver specific measures of contrast agent at particular flow rates.
A. The total market value of contrast media injectors marketis $1,405.90 million in 2020.
A. The market value of contrast media injectors market in 2030 is $2,608.20 million.
A. The base year is 2020 in mental health market
A. Top companies such as, Bayer Ag, Bracco Imaging S.P.A, Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. In product type, consumables segment depression is the most influencing segment. The high growth rate in this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures.
A. The major factor that fuels the growth of the global contrast media injectors market includes, increasing prevalence of cancer and cardiovascular diseases, artificial intelligence to provide faster results, increasing demand for MRI scans and increase in unhealthy lifestyle drive the growth of the global contrast media injectors market. However, high cost of contrast media injectors, consumables and accessories is expected to hamper the market growth.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries.This attributed to increase in health awareness, development in healthcare infrastructure, and rise in number of hospitals equipped with advanced medical facilities
A. The forcast period for contrast media injectors market is 2021 to 2030
A. radiology, interventional cardiology, and interventional radiology
Start reading instantly.
This Report and over 67,132+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report